← brief for 2026-08-13 · Slowing decline
Clinical applicability of cystatin C-based renal function assessment and HPLC-based therapeutic drug monitoring for predicting cefepime overexposure
Key takeaways
A study on using cystatin C and HPLC to monitor drug levels in patients with kidney disease. No results yet.
Who did this work
Kyohei Sugiyama · Tomoki Kimura · Nanaho Fukumoto · Madoka Kibe · Yukako Suyama · Kenta Ito · Kazuko Sakurai · Kunihiko Itoh · Tomonobu Uchino
Source
Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-13
https://doi.org/10.1186/s40780-026-00619-6